Advertisement
Wilderness & Environmental Medicine
Wilderness Medical Society
Advanced searchSave search
Research Article| Volume 1, ISSUE 2, P86-92, May 1990

High incidence of mild acute mountain sickness in conference attendees at 10 000 foot altitude

  • A.G. Dean
    Correspondence
    To whom correspondence should be addressed at: Epidemiology Program Office, Mailstop G24, Centers for Disease Control, Atlanta, GA, 30333, USA.
    Affiliations
    Division of Surveillance and Epidemiologic Studies, Epidemiology Program Office, Centers for Disease Control, Atlanta, Georgia, USA
    Search for articles by this author
  • R. Yip
    Affiliations
    Division of Nutrition, Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control, Atlanta, Georgia, USA
    Search for articles by this author
  • R.E. Hoffmann
    Affiliations
    Division of Disease Control and Environmental Epidemiology, Colorado Department of Health, Denver, Colorado, USA
    Search for articles by this author
DOI:https://doi.org/10.1580/0953-9859-1.2.86
High incidence of mild acute mountain sickness in conference attendees at 10 000 foot altitude
Previous ArticleTriggerfish bite – a little-known marine hazard
Next ArticleThe development and current status of wilderness prehospital emergency care in the United States
      This paper is only available as a PDF. To read, Please Download here.
      An epidemic of mild acute mountain sickness (AMS) occurred at a 4-day meeting of epidemiologists held at an altitude of 3000 m (9800 ft) in the Rocky Mountains of Colorado, USA. Questionnaires from 96% of the 105 attendees documented the following symptom frequencies: headache, 59%; shortness of breath, 59%; difficulty in sleeping, 45%; weakness or dizziness, 40%; and nausea, 12%. AMS, defined as three or more symptoms, occurred in 42% of the respondents, and 90% had at least one symptom. One third felt the illness interfered with their concentration at the meeting, and 31% would not plan another meeting at this altitude, although only one person missed meeting sessions as a result of the AMS. AMS should be anticipated by those planning meetings of short duration at high altitude, and by physicians advising travelers to altitudes over 2000 m.

      Keywords

      References

        • Johnson T.S.
        • Rock P.B.
        Current concepts: acute mountain sickness.
        N Eng J Med. 1988; 319: 841-845
        • Anonymous
        High altitude sickness.
        Medical Letter. 1988; 30: 89-90
        • Montgomery A.B.
        • Mills J.
        • Luce J.M.
        Incidence of acute mountain sickness at intermediate altitude.
        JAMA. 1989; 261: 732-734
        • Hackett P.H.
        • Rennie D.
        • Levine H.D.
        The incidence, importance, and prophylaxis of acute mountain sickness.
        Lancet. 1976; ii: 1149-1154
        • Houston C.S.
        Incidence of acute mountain sickness: a study of winter visitors to six Colorado resorts.
        Am Alpine J. 1985; 27: 162-165
        • Forwand S.A.
        • Landowne M.
        • Follansbee J.N.
        • et al.
        Effect of acetazolamide on acute mountain sickness.
        N Eng J Med. 1968; 279: 839-844
        • Larson E.B.
        • Roach R.C.
        • Schoene R.B.
        • Hornbein T.F
        Acute mountain sickness and acetazolamide: clinical efficacy and effect on ventilation.
        JAMA. 1982; 248: 328-332
        • Ellsworth A.J.
        • Larson D.B.
        • Strickland D.
        A randomized trial of dexamethasone and acetazolamide for acute mountain sickness prophylaxis.
        Am J Med. 1987; 83: 1024-1030
        • Dean J.A.
        • Dean A.G.
        • Burton A.
        • Dicker R.
        Epi Info computer programs for epidemiology.
        Centers for Disease Control, Atlanta, GA1988
        • Montgomery A.
        • Luce J.
        • Mills J.
        Effects of dexamethasone on the incidence of acute mountain sickness at two intermediate altitudes.
        JAMA. 1989; 261: 734-736
        • Ferrazzini G.
        • Maggiorini M.
        • Kriemler S.
        • Bartsch P.
        • Oelz O.
        Successful treatment of acute mountain sickness with dexamethasone.
        British Medical J. 1987; 294: 1380-1382
        • Harvey T.C.
        • Raichle M.E.
        • Winterborn M.H.
        • et al.
        Effect of carbon dioxide in acute mountain sickness: a rediscovery.
        Lancet. 1988; ii: 639-641
        • Hackett P.H.
        Carbon dioxide breathing and mountain sickness.
        Lancet. 1989; ii: 272-273
        • Zell S.
        • Goodman P.
        Acetazolamide and dexamethasone in the prevention of acute mountain sickness.
        Western J Med. 1988; 148: 541-545
        • Dickinson J.G.
        Acetazolamide in acute mountain sickness.
        Brit Med J. 1987; 295: 1161-1162
        • Hackett P.
        • Roach R.
        • Wood R.
        • et al.
        Dexamathasone for prevention and treatment of acute mountain sickness.
        A viat Space Environ Med. 1988; 59: 950-954

      Article info

      Identification

      DOI: https://doi.org/10.1580/0953-9859-1.2.86

      Copyright

      © 1990 Wilderness Medical Society. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX